Kamran Qureshi

763 total citations
46 papers, 529 citations indexed

About

Kamran Qureshi is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Kamran Qureshi has authored 46 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 22 papers in Hepatology and 11 papers in Surgery. Recurrent topics in Kamran Qureshi's work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (9 papers). Kamran Qureshi is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (9 papers). Kamran Qureshi collaborates with scholars based in United States, United Kingdom and India. Kamran Qureshi's co-authors include Gary A. Abrams, Ronald H. Clements, Abdullah Al‐Osaimi, Fahad Saeed, Brent A. Neuschwander‐Tetri, Stephen Lott, Hicham Khallafi, Sy Atezaz Saeed, S Rafi and Bukhtiar H. Shah and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Kamran Qureshi

34 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamran Qureshi United States 12 305 157 129 92 88 46 529
Oğuzhan Öztürk Türkiye 13 362 1.2× 112 0.7× 160 1.2× 65 0.7× 82 0.9× 29 544
Tadeja Pintar Slovenia 7 415 1.4× 116 0.7× 202 1.6× 109 1.2× 128 1.5× 23 642
Sanja Stojsavljević Croatia 9 357 1.2× 139 0.9× 127 1.0× 66 0.7× 88 1.0× 16 477
Jorge Gutiérrez‐Cuevas Mexico 8 230 0.8× 74 0.5× 110 0.9× 49 0.5× 156 1.8× 13 484
Vaishali Patel United States 13 328 1.1× 181 1.2× 119 0.9× 154 1.7× 117 1.3× 47 680
Abdullah Sonsuz Türkiye 10 222 0.7× 111 0.7× 86 0.7× 69 0.8× 49 0.6× 31 406
Andrew A. Wheeler United States 12 233 0.8× 51 0.3× 104 0.8× 179 1.9× 96 1.1× 30 494
M.A. Sardo Italy 19 188 0.6× 100 0.6× 79 0.6× 131 1.4× 154 1.8× 37 762
Vicência Mara Rodrigues de Lima Brazil 13 400 1.3× 146 0.9× 224 1.7× 185 2.0× 134 1.5× 15 679
Bing Du China 13 136 0.4× 60 0.4× 72 0.6× 76 0.8× 150 1.7× 29 504

Countries citing papers authored by Kamran Qureshi

Since Specialization
Citations

This map shows the geographic impact of Kamran Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamran Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamran Qureshi more than expected).

Fields of papers citing papers by Kamran Qureshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamran Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamran Qureshi. The network helps show where Kamran Qureshi may publish in the future.

Co-authorship network of co-authors of Kamran Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kamran Qureshi. A scholar is included among the top collaborators of Kamran Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamran Qureshi. Kamran Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shiffman, Mitchell L., K. Rajender Reddy, Michael D. Leise, et al.. (2024). Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study. Alimentary Pharmacology & Therapeutics. 61(1). 75–87. 5 indexed citations
3.
Frey, Lewis J., et al.. (2024). Evaluating the predictive power of machine learning in cirrhosis mortality: a systematic review. 8. 15–15. 2 indexed citations
4.
Farooq, Umer, et al.. (2024). Infection-Related Readmissions Are Rising among Patients with Hepatorenal Syndrome: A Nationwide Analysis. SHILAP Revista de lepidopterología. 4(2). 268–274.
5.
Mahmoud, Maya, et al.. (2024). Liver Elastography for the Detection of Methotrexate-Induced Liver Injury: A Retrospective Study. SHILAP Revista de lepidopterología. 118–125.
6.
Qureshi, Kamran, et al.. (2024). S4864 Giardia lamblia Diagnosed Incidentally by Duodenal Biopsy from Endoscopy During a Workup for a Gastrointestinal Bleed and Weight Loss. The American Journal of Gastroenterology. 119(10S). S3068–S3069.
7.
Mahmoud, Maya, et al.. (2023). S1486 Impact of Obesity on Liver Fibrosis and Steatosis in Patients Diagnosed With Methotrexate-Associated Liver Injury: A Retrospective Study. The American Journal of Gastroenterology. 118(10S). S1128–S1128. 2 indexed citations
8.
Qureshi, Kamran & Alan Bonder. (2020). Thrombopoietin-receptor agonists in perioperative treatment of patients with chronic liver disease. World Journal of Meta-Analysis. 8(3). 220–232. 2 indexed citations
9.
Qureshi, Kamran, et al.. (2019). Hepatitis C Treatment Differences in Elderly Patients: Single-Center Retrospective Study. Annals of Pharmacotherapy. 54(2). 113–121. 4 indexed citations
10.
Qureshi, Kamran & Brent A. Neuschwander‐Tetri. (2019). The molecular basis for current targets of NASH therapies. Expert Opinion on Investigational Drugs. 29(2). 151–161. 13 indexed citations
11.
Khallafi, Hicham, Nina George, & Kamran Qureshi. (2015). The Prescribers’ Dilemma: Treatment of Hepatitis C Infection for Medicaid Insured Patients in United States. 1(2). 26–31.
12.
Qureshi, Kamran, et al.. (2015). Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report. Transplantation Proceedings. 47(7). 2295–2297. 14 indexed citations
13.
Sanaka, Sirish, et al.. (2015). Severe Myositis With the Use of Sofosbuvir/Ledipasvir for Hepatitis C Infection: A Case of Unexpected Interactions. The American Journal of Gastroenterology. 110. S333–S333. 2 indexed citations
14.
Qureshi, Kamran, et al.. (2014). The Treatment of Cholangiocarcinoma: a Hepatologist’s Perspective. Current Gastroenterology Reports. 16(10). 412–412. 12 indexed citations
15.
Qureshi, Kamran & Abdullah Al‐Osaimi. (2014). Approach to the Management of Portal Hypertensive Gastropathy and Gastric Antral Vascular Ectasia. Gastroenterology Clinics of North America. 43(4). 835–847. 13 indexed citations
16.
Qureshi, Kamran, Ronald H. Clements, Fahad Saeed, & Gary A. Abrams. (2010). Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease. Journal of Obesity. 2010. 1–7. 23 indexed citations
17.
Qureshi, Kamran, Ronald H. Clements, & Gary A. Abrams. (2008). The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD. Obesity Surgery. 18(3). 264–270. 46 indexed citations
18.
Qureshi, Kamran, et al.. (2007). Intrathoracic lipoma in a child. Emergency Medicine Journal. 24(10). 695–695. 1 indexed citations
19.
Qureshi, Kamran. (2007). Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology. 13(26). 3540–3540. 212 indexed citations
20.
Shah, Bukhtiar H., A. M. Siddiqui, Kamran Qureshi, et al.. (1999). Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathways. Experimental & Molecular Medicine. 31(1). 42–46. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oğuzhan Öztürk Breakdown of academic impact, for papers by Tadeja Pintar Breakdown of academic impact, for papers by Sanja Stojsavljević Breakdown of academic impact, for papers by Jorge Gutiérrez‐Cuevas Breakdown of academic impact, for papers by Vaishali Patel Breakdown of academic impact, for papers by Abdullah Sonsuz Breakdown of academic impact, for papers by Andrew A. Wheeler Breakdown of academic impact, for papers by M.A. Sardo Breakdown of academic impact, for papers by Vicência Mara Rodrigues de Lima Breakdown of academic impact, for papers by Bing Du
Rankless by CCL
2026